Poland, July 10 -- Poland based Abbvie Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products - Delivery of a medicinal product containing the active substance Mirvetuximab soravtansine . The value of the contract is worth 3779997.84 PLN .
Published by HT Digital Content Services with permission from Pivotal Sources....